Reports › TXN › 10-Q FY2026

SEC filings, compared

What changed in Texas Instruments's 10-Q for the quarter ended March 31, 2026

Compared with the 10-Q for the quarter ended March 31, 2025. Part I, Item 2 and Part II, Item 1A analysed; every summary checked against the quoted filing text.

Registrant: TEXAS INSTRUMENTS INC · TXN
This filing: 0000097476-26-000101 ↗ · filed Apr 24, 2026
Compared with: 0000097476-25-000027 ↗ · filed Apr 24, 2025
Processed: Sep 20, 2026 UTC · parser-v5 · classify-v4 · select-v1

Research tool. Describes what filings say. Not investment advice. Verify independently. Read the cited paragraph before relying on it.

How a report is made

29 material changes among 46 changed paragraphs

15 shown by default across the three sections below; each section's "Show all" reaches the rest, in filing order.

Numbers from XBRL

Each figure is the one the filing itself tagged, taken from the filing that reported it. Not written by a model.

Concept	FY2026	FY2025	Change (our arithmetic)
Revenueus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax	4,825,000,000USD · Jan 1, 2026 to Mar 31, 2026	4,069,000,000USD · Jan 1, 2025 to Mar 31, 2025	+756,000,000+18.6%
Net income or lossus-gaap:NetIncomeLoss	1,545,000,000USD · Jan 1, 2026 to Mar 31, 2026	1,179,000,000USD · Jan 1, 2025 to Mar 31, 2025	+366,000,000+31%
Cash and cash equivalentsus-gaap:CashAndCashEquivalentsAtCarryingValue	3,549,000,000USD · at Mar 31, 2026	2,763,000,000USD · at Mar 31, 2025	+786,000,000+28.4%
Net cash from operating activitiesus-gaap:NetCashProvidedByUsedInOperatingActivities	1,520,000,000USD · Jan 1, 2026 to Mar 31, 2026	849,000,000USD · Jan 1, 2025 to Mar 31, 2025	+671,000,000+79%

Values as tagged in the filing's inline XBRL, resolved by accession rather than by period matching. When a value is not tagged, we show that instead of estimating it. FY2026: 0000097476-26-000101 · FY2025: 0000097476-25-000027

What the company says for the first time

Paragraphs with no counterpart in the prior filing.

10 material additions

Part I, Item 2 · MD&A

8 of 10 shown · Ordered by the model, quote-checked

01AddedPart I, Item 2 › Acquisition of Silicon Labs

Summary · quote-checked

Added disclosure of a definitive agreement to acquire Silicon Labs, including transaction value, financing, expected closing timing, and required approvals.

The new paragraph introduces a significant acquisition, associated debt financing and cash use, regulatory and shareholder approvals, and closing conditions.

Why the model ranked it here

The agreement introduces a major acquisition, substantial funding and cash-use commitments, and approval and closing conditions that could materially change the company’s scope and financial profile.

Filing text · FY2025 10-Q · filed Apr 24, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Apr 24, 2026

[added] As announced on February 4, 2026, we have entered into a definitive agreement to acquire Silicon Labs for $231.00 per share in an all-cash transaction, representing a total enterprise value of approximately $7.5 billion. Under the terms of the agreement, Silicon Labs stockholders will receive $231.00 in cash for each share of Silicon Labs common stock they hold at the time of closing, which is currently expected in the first half of 2027, subject to receipt of regulatory approvals and other customary closing conditions, including approval by Silicon Labs stockholders. We expect to fund the transaction with a combination of cash on hand and debt financing to be arranged prior to closing.

Cite this change

"As announced on February 4, 2026, we have entered into a definitive agreement to acquire Silicon Labs for $231.00 per share in an all-cash transaction, representing a total enterprise value of approximately $7.5 billion."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

02AddedPart I, Item 2 › Manufacturing

Summary · quote-checked

Added disclosure describing a six-year elevated capital expenditures cycle, its nearing completion, and expected manufacturing capacity and free cash flow benefits.

The paragraph introduces substantive information about capital expenditure commitments, manufacturing capacity, scalability, and stated long-term financial benefits, rather than merely updating wording or dates.

Why the model ranked it here

The disclosure explains that a prolonged period of elevated investment is nearing completion and links the resulting capacity to expected scalability and free cash flow benefits.

Filing text · FY2025 10-Q · filed Apr 24, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Apr 24, 2026

[added] We continue to invest to strengthen our competitive advantage in manufacturing and technology as part of our long-term capacity plan. We are nearing the end of a six-year elevated capital expenditures cycle that, when completed, will uniquely position TI to deliver dependable, low-cost 300mm capacity, scalability of capital expenditures, including capacity modularity, and free cash flow per share growth across a range of market conditions.

Cite this change

"We continue to invest to strengthen our competitive advantage in manufacturing and technology as part of our long-term capacity plan. We are nearing the end of a six-year elevated capital expenditures cycle that, when completed, will uniquely position TI to deliver dependable, low-cost 300mm capacity, scalability of capital expenditures, including capacity modularity, and free cash flow per share growth across a range of market conditions."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

03AddedPart I, Item 2 › Manufacturing

Summary · quote-checked

Added a manufacturing discussion describing owned production capabilities, supply-chain control, geopolitical capacity benefits, cost advantages, and selective outside-supplier use.

A newly disclosed paragraph adds substantive information about manufacturing ownership, geographic facilities, cost structure, capacity reliability, and supplier dependency; the change is not merely a presentation update.

Why the model ranked it here

The manufacturing strategy describes ownership of production and technology as a source of cost, supply-chain, and geopolitical advantages while clarifying reliance on outside suppliers.

Filing text · FY2025 10-Q · filed Apr 24, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Apr 24, 2026

[added] We invest to make manufacturing and technology a core competitive advantage. The strategic decision to own our manufacturing, process and packaging technology provides us with tangible benefits of lower manufacturing costs and greater control of our supply chain and provides our customers with geopolitically dependable capacity. We own and operate both wafer fabrication and assembly/test facilities in North America, Asia, Japan and Europe. We have focused on creating a competitive structural cost advantage by investing in our 300mm wafer production, which describes the diameter of the wafer on which our chips are produced, and costs about 40% less than a chip built on a 200mm wafer. In addition, we selectively use capacity of outside suppliers, commonly known as foundries and subcontractors.

Cite this change

"We invest to make manufacturing and technology a core competitive advantage. The strategic decision to own our manufacturing, process and packaging technology provides us with tangible benefits of lower manufacturing costs and greater control of our supply chain and provides our customers with geopolitically dependable capacity."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

04AddedPart I, Item 2 › Results of operations

Summary · quote-checked

Added disclosure that LFAB is ramping production and that its costs are expected to disproportionately benefit Embedded Processing operating profit over Analog.

The new paragraph introduces a facility ramp, expected factory-loading changes, and a stated operating-profit allocation effect, changing the disclosed business outlook.

Why the model ranked it here

The facility ramp changes the disclosed operating outlook by indicating increasing factory utilization and a differing effect on the company’s business segments.

Filing text · FY2025 10-Q · filed Apr 24, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Apr 24, 2026

[added] ◦ Our LFAB facility, which primarily supports our Embedded Processing business, was purchased as an operating fab and is continuing to ramp production, so we expect factory loadings to increase over time. As LFAB ramps, we expect Embedded to carry manufacturing costs that disproportionately benefit Embedded Processing operating profit as compared to Analog.

Cite this change

"Our LFAB facility, which primarily supports our Embedded Processing business, was purchased as an operating fab and is continuing to ramp production, so we expect factory loadings to increase over time."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

05AddedPart I, Item 2 › Details of financial results - first quarter 2026 compared with first quarter 2025

Summary · quote-checked

Added disclosure of $17 million in acquisition charges tied to transaction-related costs for the planned Silicon Labs acquisition.

The new paragraph discloses a specific transaction, related costs, and a planned acquisition, introducing substantive information about an obligation and corporate event.

Why the model ranked it here

The acquisition-related charges establish an immediate transaction cost and confirm that the planned acquisition is already affecting reported results.

Filing text · FY2025 10-Q · filed Apr 24, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Apr 24, 2026

[added] Acquisition charges were $17 million due to transaction-related costs associated with our planned acquisition of Silicon Labs.

Cite this change

"Acquisition charges were $17 million due to transaction-related costs associated with our planned acquisition of Silicon Labs."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

06AddedPart I, Item 2 › Macroeconomic factors

Summary · quote-checked

Added discussion of semiconductor market recovery, demand drivers, macroeconomic uncertainty, and inventory and capacity positioning.

The new paragraph adds substantive market conditions, demand explanations, and management’s stated inventory and capacity outlook, rather than merely updating wording or dates.

Why the model ranked it here

The disclosure presents a continuing market recovery alongside macroeconomic uncertainty and states that inventory and capacity are positioned to support customers.

Filing text · FY2025 10-Q · filed Apr 24, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Apr 24, 2026

[added] In first quarter, the overall analog and embedded semiconductor market recovery continued. While uncertainty related to broader macroeconomic dynamics remains, growth of semiconductor content in electronics has continued to drive demand for our products, particularly in the industrial, automotive and data center markets. We believe we are well positioned with inventory and capacity to support our customers with competitive lead times through the semiconductor cycle.

Cite this change

"In first quarter, the overall analog and embedded semiconductor market recovery continued. While uncertainty related to broader macroeconomic dynamics remains, growth of semiconductor content in electronics has continued to drive demand for our products, particularly in the industrial, automotive and data center markets. We believe we are well positioned with inventory and capacity to support our customers with competitive lead times through the semiconductor cycle."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

07AddedPart I, Item 2 › Manufacturing

Summary · quote-checked

Added disclosure describing planned capacity expansions, increasing internal sourcing, manufacturing capacity, and equipment purchases supporting technology development and revenue growth.

The new paragraph adds substantive expectations about manufacturing capacity, sourcing, equipment needs, and support for future demand and growth.

Why the model ranked it here

The planned capacity expansion and greater internal sourcing indicate a changing production footprint intended to support future demand and technology development.

Filing text · FY2025 10-Q · filed Apr 24, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Apr 24, 2026

[added] With our planned capacity expansions to support demand over time, we expect our internal sourcing to continue to increase. We expect to continue to maintain sufficient internal manufacturing capacity to meet the majority of our production needs and to obtain manufacturing equipment to support new technology developments and revenue growth.

Cite this change

"With our planned capacity expansions to support demand over time, we expect our internal sourcing to continue to increase."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

08AddedPart I, Item 2 › Inventory

Summary · quote-checked

Added MD&A disclosure describing inventory objectives and a strategy to build ahead of demand for broad-based, low-obsolescence products.

The new paragraph introduces substantive inventory-management objectives, demand-planning practices, and factors affecting inventory levels, rather than merely changing presentation or boilerplate.

Why the model ranked it here

The inventory strategy clarifies how the company balances customer service, lead times, obsolescence, and manufacturing utilization when planning supply.

Filing text · FY2025 10-Q · filed Apr 24, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Apr 24, 2026

[added] Our objectives for inventory are to maintain high levels of customer service, maintain dependable and competitive lead times, minimize inventory obsolescence and improve manufacturing asset utilization. To meet these objectives and to allow greater flexibility in periods of high demand, our strategy is to build ahead of demand our broad-based products that are used across a diverse set of applications and customers and have low risk of obsolescence. Inventory levels will vary based on market conditions and seasonality. We adjust factory loadings as needed to execute on this inventory strategy.

Cite this change

"Our objectives for inventory are to maintain high levels of customer service, maintain dependable and competitive lead times, minimize inventory obsolescence and improve manufacturing asset utilization."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

Show all 10 in Part I, Item 2 (2 more, in filing order)

What the company no longer says

Paragraphs of the prior filing that this filing dropped. Only last year's text can show these.

2 material removals

Part I, Item 2 · MD&A

2 of 2 shown · In filing order, too few to rank

01RemovedPart I, Item 2 › Overview

Summary · quote-checked

Removed disclosure that geopolitical developments could affect customers, suppliers, demand, and the supply chain, while reporting no current second-quarter impact.

The removed paragraph disclosed an uncertain geopolitical risk and its potential business effects; dropping that disclosure changes the stated risk coverage, despite the prior no-impact statement.

Filing text · FY2025 10-Q · filed Apr 24, 2025

[removed] We are monitoring the geopolitical environment. Any implication to our customers, suppliers or TI's business, including customer demand and our supply chain, is uncertain and will likely evolve. We currently do not see impact to second-quarter results.

Filing text · FY2026 10-Q · filed Apr 24, 2026

No corresponding language in the FY2026 10-Q.

Cite this change

"We are monitoring the geopolitical environment. Any implication to our customers, suppliers or TI's business, including customer demand and our supply chain, is uncertain and will likely evolve. We currently do not see impact to second-quarter results."

Texas Instruments, Form 10-Q for FY2025, Part I, Item 2, accession 0000097476-25-000027, filed 24 April 2025.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747625000027/txn-20250331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

02RemovedPart I, Item 2 › Results of operations - first quarter 2025 compared with first quarter 2024

Summary · quote-checked

The current report removes the explanation that prior-period restructuring charges reflected a credit primarily from a property-sale gain.

The removed MD&A paragraph disclosed a specific prior-period result and its driver, rather than merely rolling forward a date, period, or recurring table.

Filing text · FY2025 10-Q · filed Apr 24, 2025

~~[removed] Restructuring charges/other in the year-ago period was a credit of $124 million primarily due to a gain on the sale of a property during 2024.~~

Filing text · FY2026 10-Q · filed Apr 24, 2026

No corresponding language in the FY2026 10-Q.

Cite this change

"Restructuring charges/other in the year-ago period was a credit of $124 million primarily due to a gain on the sale of a property during 2024."

Texas Instruments, Form 10-Q for FY2025, Part I, Item 2, accession 0000097476-25-000027, filed 24 April 2025.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747625000027/txn-20250331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

What the company says differently

Paragraphs that changed between the two filings, shown as a word diff.

17 material changes

Part I, Item 2 · MD&A

5 of 17 shown · Ordered by the model, quote-checked

01ChangedPart I, Item 2 › Liquidity and capital resources

Summary · quote-checked

Investing cash flow changed from $1.25 billion provided to $47 million used, with lower capital expenditures and revised CHIPS Act funding descriptions.

The cash-flow direction changed, and the CHIPS Act proceeds changed from investment tax credit-related proceeds to direct funding, substantively altering the liquidity explanation.

Why the model ranked it here

This changes investing cash flow from a source to a use and revises the explanation of government funding, materially altering the liquidity picture.

Filing text · FY2025 10-Q · filed Apr 24, 2025

Investing activities for the first three months of ~~[removed] 2025 provided $1.25 billion~~ compared with ~~[removed] $3.33~~ billion of cash ~~[removed] used~~ in the year-ago period. Capital expenditures were ~~[removed] $1.12 billion~~ compared with ~~[removed] $1.25~~ billion in the year-ago period and were primarily for semiconductor manufacturing equipment and facilities in both periods. ~~[removed] In 2025, we received~~ proceeds of $260 million ~~[removed] from U.S. CHIPS and Science Act (CHIPS Act) incentives.~~ Short-term investments provided cash of ~~[removed] $2.16 billion~~ compared with ~~[removed] $2.23 billion of cash used~~ in the year-ago period.

Filing text · FY2026 10-Q · filed Apr 24, 2026

Investing activities for the first three months of [added] 2026 used $47 million compared with [added] $1.25 billion of cash [added] provided in the year-ago period. Capital expenditures were [added] $676 million compared with [added] $1.12 billion in the year-ago period and were primarily for semiconductor manufacturing equipment and facilities in both periods. [added] U.S. CHIPS and Science Act (CHIPS Act) incentives provided cash proceeds of [added] $555 million of direct funding compared with $260 million [added] related to the investment tax credit (ITC) in the year-ago period. Short-term investments provided cash of [added] $108 million compared with [added] $2.16 billion in the year-ago period.

Cite this change

"Investing activities for the first three months of 2026 used $47 million compared with $1.25 billion of cash provided in the year-ago period."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

02ChangedPart I, Item 2 › Liquidity and capital resources

Summary · quote-checked

Financing cash use, debt activity, dividends, repurchases, and option-exercise proceeds were updated, while prior-period debt issuance detail was omitted.

The financing narrative changes reported cash-flow direction and drivers, including removal of debt issuance proceeds and revised debt timing; this is substantive beyond a routine period roll-forward.

Why the model ranked it here

This changes the financing cash-flow narrative through debt retirement, revised debt activity, distributions, repurchases, and omitted issuance proceeds.

Filing text · FY2025 10-Q · filed Apr 24, 2025

Financing activities for the first three months of ~~[removed] 2025 used $2.54~~ billion compared with ~~[removed] $1.83 billion of cash provided~~ in the year-ago period. ~~[removed] In 2025, we~~ retired maturing debt of $750 ~~[removed] million. In~~ the year-ago ~~[removed] period, we received net proceeds of $2.98 billion from the issuance of fixed-rate, long-term debt.~~ Dividends paid were ~~[removed] $1.24~~ billion compared with ~~[removed] $1.18~~ billion in the year-ago period, reflecting an increased dividend rate. We used ~~[removed] $653~~ million to repurchase ~~[removed] 3.5~~ million shares of our common stock compared with ~~[removed] $3 million~~ in the year-ago period. Employee exercises of stock options provided cash proceeds of ~~[removed] $118~~ million compared with ~~[removed] $65~~ million in the year-ago period.

Filing text · FY2026 10-Q · filed Apr 24, 2026

Financing activities for the first three months of [added] 2026 used $1.15 billion compared with [added] $2.54 billion in the year-ago period. [added] We retired maturing debt of $750 [added] million in the year-ago [added] period. Dividends paid were [added] $1.29 billion compared with [added] $1.24 billion in the year-ago period, reflecting an increased dividend rate. We used [added] $158 million to repurchase [added] 0.8 million shares of our common stock compared with [added] $653 million to repurchase 3.5 million shares in the year-ago period. Employee exercises of stock options provided cash proceeds of [added] $309 million compared with [added] $118 million in the year-ago period.

Cite this change

"We retired maturing debt of $750 million in the year-ago period."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

03ChangedPart I, Item 2 › Liquidity and capital resources

Summary · quote-checked

Operating cash flow changed from a year-over-year decrease to an increase, with different stated drivers and updated amounts.

The MD&A reverses the direction of cash-flow change and replaces the stated drivers, making the liquidity discussion substantively different beyond a period roll-forward.

Why the model ranked it here

This reverses the direction of operating cash-flow change and identifies different drivers, materially changing the assessment of cash generation.

Filing text · FY2025 10-Q · filed Apr 24, 2025

Our primary source of liquidity is cash flow from operations. Additional sources of liquidity are cash and cash equivalents, short-term investments and access to debt markets. We also have a variable-rate, revolving credit facility. As of March 31, ~~[removed] 2025,~~ our credit facility was undrawn, and we had no commercial paper outstanding. Cash flows from operating activities for the first three months of ~~[removed] 2025 were $849 million, a decrease of $168~~ million from the year-ago period ~~[removed] primarily~~ due to higher ~~[removed] cash used for working capital, partially offset by higher net income.~~

Filing text · FY2026 10-Q · filed Apr 24, 2026

Our primary source of liquidity is cash flow from operations. Additional sources of liquidity are cash and cash equivalents, short-term investments and access to debt markets. We also have a variable-rate, revolving credit facility. As of March 31, [added] 2026, our credit facility was undrawn, and we had no commercial paper outstanding. Cash flows from operating activities for the first three months of [added] 2026 were $1.52 billion, an increase of $671 million from the year-ago period due to higher [added] net income and non-cash items, as well as lower cash used for working capital.

Cite this change

"Cash flows from operating activities for the first three months of 2026 were $1.52 billion, an increase of $671 million from the year-ago period due to higher net income and non-cash items, as well as lower cash used for working capital."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

04ChangedPart I, Item 2 › Financial condition

Summary · quote-checked

The reported cash position shifted from a decrease to an increase, with total cash and comparison periods also changing.

The statement changes the direction of cash movement from a decrease to an increase, substantively altering the reported liquidity trend rather than merely rolling forward dates.

Why the model ranked it here

This changes the reported cash trend from a decline to an increase, directly altering the stated liquidity position.

Filing text · FY2025 10-Q · filed Apr 24, 2025

At the end of the first quarter of ~~[removed] 2025,~~ total cash (cash and cash equivalents plus short-term investments) was ~~[removed] $5.01 billion, a decrease of $2.58 billion~~ from the end of ~~[removed] 2024.~~

Filing text · FY2026 10-Q · filed Apr 24, 2026

At the end of the first quarter of [added] 2026, total cash (cash and cash equivalents plus short-term investments) was [added] $5.10 billion, an increase of $222 million from the end of [added] 2025.

Cite this change

"At the end of the first quarter of 2026, total cash (cash and cash equivalents plus short-term investments) was $5.10 billion, an increase of $222 million from the end of 2025."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

05ChangedPart I, Item 2 › Liquidity and capital resources

Summary · quote-checked

The disclosure changes the capital-expenditure outlook and updates the tax-credit and funding status for qualifying manufacturing investments.

The company now states elevated spending is nearing its end, introduces future spending dependence on revenue and growth, and reports changed credit and funding details.

Why the model ranked it here

This signals that the elevated investment cycle is nearing completion and makes future capital spending dependent on revenue and growth expectations.

Filing text · FY2025 10-Q · filed Apr 24, 2025

[removed] As we continue to invest to strengthen our competitive advantages in manufacturing and technology, as part of our long-term capacity planning, our capital expenditures are expected to remain at elevated levels. For qualifying manufacturing investments, we expect to ~~[removed] benefit~~ from the ~~[removed] 25% investment tax credit (ITC) established by the CHIPS Act,~~ as well as direct funding of up to $1.6 ~~[removed] billion~~ for our three large-scale 300mm wafer fabs ~~[removed] currently under construction~~ in Sherman, Texas, and Lehi, Utah.

Filing text · FY2026 10-Q · filed Apr 24, 2026

[added] We are nearing the end of our six-year elevated capital expenditures cycle, and consistent with our capital management strategy, we are expecting to spend about $2 billion to $3 billion in 2026. Beyond 2026, capital expenditures will be dependent on revenue and growth expectations. We expect to [added] continue benefiting from the [added] CHIPS Act. This includes the 35% ITC on qualifying manufacturing investments as well as direct funding of up to $1.6 [added] billion, of which we have received $630 million, for our three large-scale 300mm wafer fabs [added] located in Sherman, Texas, and Lehi, Utah.

Cite this change

"We are nearing the end of our six-year elevated capital expenditures cycle, and consistent with our capital management strategy, we are expecting to spend about $2 billion to $3 billion in 2026. Beyond 2026, capital expenditures will be dependent on revenue and growth expectations."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000101, filed 24 April 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000101/txn-20260331.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000101?ref=quote

Show all 17 in Part I, Item 2 (12 more, in filing order)

What the company reported as changed this quarter

We have not parsed the annual report this quarter's risk factors refers to, so we cannot tell whether it restates the section or reports changes to it. Nothing is compared until we can.

Part II, Item 1A · Risk Factors

Get this when TXN files next

At most one email a day, and only when a company we cover files. Over the last twelve months that averaged about 5 days a month, unevenly: 12 in the busiest month and 1 in the quietest. You confirm by email first; nothing is sent until you do.